Loading
The Neuroscience Chronicles
ISSN: 2767-3405
Editor Info
Zhou Zhidong
National University of Singapore
Singapore
Academic Editor
Biography
Dr Zhou graduated as a Medical Doctor (MD) in 1991 and had 5 years of postgraduate clinical training in Internal Medicine (IM). Subsequently he acquired his PhD from Chinese Academy of Science (CAS) and received his post-doctor training on PD research in NUS from 2003. Later he joined NNI as a member of the National PD Translational Bench to Bedside team and continue to work on PD. Currently, he is a Principal Investigator & Clinician Scientist at NNI and a regular rank Assistant Professor of NBD, Duke-NUS as well as a PI of NMRC, SHF and Duke-NUS grants. Currently Dr Zhou is supported by funding from multiple NMRC CS-IRG, OF-IRG, HLCA and Singhealth-DUKE-NUS grants. Dr Zhou is a instruction mentor of DUKE-NUS and an Industry Partner of NTU and Polytechnic as well as overseas institutes. So far he has trained and instructed more than eighty undergraduate, graduate, Master and PhD students as well as junior researchers. Dr Zhou serves as an invited reviewer, editorial board member and editor for more than 100 journals of multiple publishing presses, including Dove, Taylor & Francis, Elsevier, MDPI, MPS, MESRS, Springer Nature, ARES, PLOS, Frontiers, Wiley, and Oxford University Press to assess and improve the quality of works from other researchers. Dr Zhou have comprehensive and sophisticated backgrounds and experience in Medicine, Biochemistry, Biophysics and Neuroscience. His research expertise is on neurodegenerative diseases with specific focuses on novel therapeutic targets, neuroprotective agents and biomarkers in PD and neurodegenerative diseases, which target to improve diagnosis, prognosis prediction and therapeutic intervention of neurodegenerative disorders. He has published more than seventy peer-reviewed papers on neurodegenerative diseases in impactful journals, including JAMA Neurology, Mol Neurodegeneration, Translational Neurodegeneration, Human Mol Genetics, Science Signaling, Nature Reviews Neurology, which have shaped our understanding of neurodegenerative disorders and benefit our patients.